Type of Posting: Revision Bulletin
Posting Date: 30–Jan–2015
Official Date: 01–Feb–2015
Expert Committee: Monographs—Small Molecules 3
Reason for Revision: Compliance
In accordance with the Rules and Procedures of the 2010-2015 Council of Experts, the Monographs—Small Molecules 3 Expert Committee has revised the Desoxycorticosterone Pivalate Injectable Suspension monograph. The purpose for the revision is to increase the upper limit of the melting point acceptance criteria from 204° to 206° in the test for Identification A.
The Desoxycorticosterone Pivalate Injectable Suspension Revision Bulletin supersedes the currently official monograph. The Revision Bulletin will be incorporated in the Second Supplement to USP 38–NF 33.
Should you have any questions, please contact Morgan Puderbaugh, Scientific Liaison (301–998–6833 or email@example.com).